KBC Group NV Has $67.85 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

KBC Group NV lessened its position in Colgate-Palmolive (NYSE:CL - Free Report) by 19.8% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 653,635 shares of the company's stock after selling 161,372 shares during the period. KBC Group NV owned approximately 0.08% of Colgate-Palmolive worth $67,854,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in CL. E Fund Management Hong Kong Co. Ltd. purchased a new position in shares of Colgate-Palmolive in the 2nd quarter valued at about $25,000. Continuum Advisory LLC increased its holdings in Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $42,000. Capital Performance Advisors LLP purchased a new position in Colgate-Palmolive during the 3rd quarter valued at about $53,000. Finally, Gradient Investments LLC increased its holdings in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Trading Up 0.4 %

Colgate-Palmolive stock traded up $0.39 during mid-day trading on Thursday, hitting $91.46. The stock had a trading volume of 2,307,565 shares, compared to its average volume of 4,363,653. The stock has a 50-day simple moving average of $99.94 and a two-hundred day simple moving average of $98.48. The stock has a market capitalization of $74.72 billion, a PE ratio of 26.10, a P/E/G ratio of 3.27 and a beta of 0.42. Colgate-Palmolive has a 12 month low of $75.17 and a 12 month high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.19%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive's dividend payout ratio (DPR) is currently 57.31%.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the stock. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target on the stock. Barclays raised their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a research report on Monday, July 29th. Jefferies Financial Group cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and decreased their target price for the stock from $103.00 to $95.00 in a research report on Wednesday, July 24th. Sanford C. Bernstein raised their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a "market perform" rating in a research report on Tuesday, July 30th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a "buy" rating to a "hold" rating and lifted their price target for the company from $107.00 to $109.00 in a research report on Monday, September 9th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $105.11.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company's stock, valued at $3,456,283.86. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business's stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Martina Hundmejean sold 2,313 shares of the business's stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.34% of the company's stock.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.